Roivant Sciences Ltd. - 10-Q Filing

Roivant Sciences Ltd. reports Q3 2026 financial results including significant investment holdings in Datavant and Arbutus Biopharma.

SEC EDGAR · November 9, 2026, 12:36 UTC

Tickers: $ROIV

More Regulatory news

M-tron Industries, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 13:56 UTC
M-tron Industries, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:55 UTC
NVIDIA CORP - 8-K Filing SEC EDGAR · November 12, 2026, 13:52 UTC
COVENANT LOGISTICS GROUP, INC. - 8-K Filing SEC EDGAR · November 12, 2026, 13:52 UTC
CuriosityStream Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 13:52 UTC
Star Equity Holdings, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:52 UTC
DeFi Development Corp. - 10-Q Filing SEC EDGAR · November 12, 2026, 13:51 UTC
BALTIC INTERNATIONAL USA INC - 10-Q Filing SEC EDGAR · November 12, 2026, 13:49 UTC
Forbright, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:50 UTC
Boxlight Corp - 8-K Filing SEC EDGAR · November 12, 2026, 13:50 UTC